Navigation Links
NJ Docs Say Cancer Detection Tool Saves Lives
Date:10/10/2011

SHORT HILLS, N.J., Oct. 10, 2011 /PRNewswire/ -- The New Jersey Patient Care and Access Coalition (NJPCAC), representing more than 200 urologists in the Garden State, encourages men and their families to speak out to preserve prostate cancer screenings. Last week, the U.S. Preventive Services Task Force (USPSTF) recommended healthy men should no longer receive prostate-specific antigen (PSA) blood tests as part of routine cancer screening.

This decision was made by a panel that does not include a single urologist or oncologist. In fact, no new research has been cited that would call for this drastic change in prostate cancer testing recommendations since the USPSTF considered this issue just two years ago in 2009.

Newer studies have found that deaths from prostate cancer dropped 44 percent among screened men over a 14-year period, when compared with unscreened men, and found screening efficiency for prostate cancer similar to other cancers.

This is the same task force that suggested mammograms were unnecessary for women ages 40- 49 and recommended against teaching women breast self exams. That recommendation caused a public outcry and was soundly rejected by Congress.

The NJPCAC believes the USPSTF recommendations jeopardize the health of countless Americans and needlessly puts in harm's way the men who are most at risk: those who are underinsured, live in areas where health care is not readily available, have a family history of prostate cancer, and particularly African-Americans (who have the highest incidence of and death rates from prostate cancer). NJPCAC supports current recommendations endorsing PSA screening for well-informed men who wish to pursue early diagnosis.

"These recent recommendations by the government fail to protect our nation's health," said Dr. David Taylor, NJPCAC Chairman and President and President of Garden State Urology in Whippany. "There is no more important element to saving the lives of men who develop prostate cancer than early detection. These recommendations threaten to reverse two decades of progress in reducing deaths from prostate cancer. Even with our recent successes, prostate cancer is still the second leading cause of cancer death in men."

NJPCAC encourages all concerned citizens to contact policymakers to demand the government not restrict access to this life-saving testing.

About

The New Jersey Patient Care and Access Coalition (NJPCAC) was organized to promote and represent the common interests of urological care physicians in the State of New Jersey who are dedicated to the highest standards of practice and focused on addressing the challenges that confront our healthcare system.

NJPCAC's membership includes nearly 200 practicing urologists and scores of additional healthcare professionals, including radiation oncologists, pathologists, nurses and administrative staff, who have come together to educate policy makers, regulators, insurers and other key stakeholders, including patients and peers about legislative and regulatory changes that could adversely affect the quality and accessibility to care provided to patients in New Jersey and those that could advance care in New Jersey. Visit www.njpcac.org for more information about NJPCAC.

FOR MORE INFORMATION Donald Sico
dsiconj@gmail.com  
856-314-8066


'/>"/>
SOURCE New Jersey Patient Care and Access Coalition
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Cancer Patients Can Benefit From Early Detection Of Heart Damage Using Echocardiography
2. Solos Endoscopy to Support National Breast Cancer Foundation With Sales of Its MammoView® Breast Endoscopy Components to US Hospitals
3. New Research Shows PET Imaging Effective in Predicting Lung Cancer Outcomes
4. Aethlon Medical Announces Hemopurifier® and HER2osome™ Cancer Therapy Presentation at Exosomes and Microvesicles 2011
5. In Honor of National Breast Cancer Awareness Month, Alma Lasers Launches Nationwide Radiation Tattoo Removal Program, Declare Your Freedom
6. Journal of Clinical Oncology Publishes Phase 2 Clinical Trial Results of KRX-0401 (Perifosine) Plus Capecitabine in Patients with Metastatic Colorectal Cancer
7. Halozyme Begins Randomized, Controlled Clinical Trial with PEGPH20 in Patients with Advanced Pancreatic Cancer
8. Inovio Pharmaceuticals Synthetic Vaccine for Cancer Recognized as Most Promising Research at Global Vaccine Congress
9. Media Alert: Elekta to Present $50,000 to Miami-Based Sandy B. Muller Breast Cancer Foundation at ASTRO Annual Meeting
10. Triple Analysis: Apoptosis, Cancer Vaccines and Antibodies
11. The US Oncology Network Affiliated Physicians at Forefront of Cutting-Edge Prostate Cancer Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 2016 Research and Markets has announced ... Diagnostic Tests" report to their offering. ... The World Market for Companion Diagnostics covers ... Market analysis in the report includes the following: ... Diagnostic Kits) by Region (N. America, EU, ROW), 2015-2020 ...
(Date:6/23/2016)... , June 23, 2016  MedSource announced today ... its e-clinical software solution of choice.  This latest ... possible value to their clients by offering a ... preferred relationship establishes nowEDC as the EDC platform ... MedSource,s full-service clients.  "nowEDC has long been a ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Experts ... applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention ... health care topics including advance care planning, healthcare costs and patient and family ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern ... Laude and his M.D from the David Geffen School of Medicine at UCLA. He ... Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program ...
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... Those ... deal with these feelings, many turn to unhealthy avenues, such as drug or alcohol ... of Marne, Michigan, has released tools for healthy coping following a traumatic event. , ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda ... orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including ... accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. ...
(Date:6/24/2016)... York, NY (PRWEB) , ... June 24, 2016 ... ... publication Haute Living, is proud to recognize Dr. Barry M. Weintraub as a ... that “the most beautiful women in the world, and the most handsome men, ...
Breaking Medicine News(10 mins):